Dr. Lalchandani-Lalwani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4430 Arapahoe Ave
Ste 115
Boulder, CO 80303Phone+1 303-900-8507Fax+1 303-578-2173
Summary
- Dr. Geeta Lalwani is a retina specialist in Boulder, CO is affiliated with Boulder Community Hospital and Longmont United Hospital. She received her medical degree from Drexel University College of Medicine and has been in practice for 14 years. Dr. Lalwani accepts several types of health insurance.
Education & Training
- University of Miami Hospital and ClinicsFellowship, Surgical Retina and Vitreous, 2005 - 2007
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Ophthalmology, 2002 - 2005
- Chestnut Hill HospitalInternship, Transitional Year, 2001 - 2002
- Drexel University College of MedicineClass of 2001
Certifications & Licensure
- CO State Medical License 2012 - 2025
- FL State Medical License 2005 - 2014
- PA State Medical License 2001 - 2002
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 686 citationsA variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung, Sander R. Dubovy, Stephen Michels
American Journal of Ophthalmology. 2009-07-01 - 768 citationsAn optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld, Sander R. Dubovy, Stephan Michels
American Journal of Ophthalmology. 2007-04-01 - 140 citationsAcute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.Geeta A. Lalwani, Harry W. Flynn, Ingrid U. Scott, Carolyn M. Quinn, Audina M. Berrocal
Ophthalmology. 2008-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: